Post-Activity Test and Activity Evaluation POST TEST Question Title * 1. Compared to those without insomnia, those with insomnia have a higher risk of: Diabetes Hypertension Depression All of the above Question Title * 2. Risk factors for insomnia include all of the following except: Older age Cigarette smoking Regular exercise Alcohol or caffeine consumption Question Title * 3. When should the primary care provider ask a patient about sleep problems? During a routine health assessment visit During an acute care visit During follow-up visits All of the above Question Title * 4. First-line management approach for the treatment of insomnia is: Sleep hygiene and cognitive behavioral therapy Benzodiazepine-receptor agonist Sedating antidepressant Melatonin supplement Question Title * 5. Orexin-receptor antagonists (e.g., suvorexant) can be considered for use in patients that have issues with: Sleep onset only Sleep maintenance only Sleep onset or sleep maintenance Neither sleep onset nor sleep maintenance Question Title * 6. In the SUNRISE-1 clinical trial that compared lemborexant with zolpidem ER and placebo for insomnia, which of the following is true? Lemborexant significantly improved sleep onset only when compared to zolpidem ER and placebo Lemborexant significantly improved sleep maintenance only when compared to zolpidem ER and placebo Lemborexant significantly improved sleep onset and sleep maintenance when compared to zolpidem ER and placebo There was no difference in sleep onset or sleep maintenance with lemborexant compared to zolpidem ER or placebo Next